Respiratory virus infections after allogeneic stem cell transplantation: Current understanding, knowledge gaps, and recent advances

Before the COVID‐19 pandemic, common community‐acquired seasonal respiratory viruses (CARVs) were a significant threat to the health and well‐being of allogeneic hematopoietic cell transplant (allo‐HCT) recipients, often resulting in severe illness and even death. The pandemic has further highlighte...

Full description

Saved in:
Bibliographic Details
Published inTransplant infectious disease Vol. 25; no. S1; pp. e14117 - n/a
Main Authors Piñana, Jose L., Pérez, Ariadna, Chorão, Pedro, Guerreiro, Manuel, García‐Cadenas, Irene, Solano, Carlos, Martino, Rodrigo, Navarro, David
Format Journal Article
LanguageEnglish
Published Denmark Wiley Subscription Services, Inc 01.11.2023
Subjects
Online AccessGet full text
ISSN1398-2273
1399-3062
1399-3062
DOI10.1111/tid.14117

Cover

More Information
Summary:Before the COVID‐19 pandemic, common community‐acquired seasonal respiratory viruses (CARVs) were a significant threat to the health and well‐being of allogeneic hematopoietic cell transplant (allo‐HCT) recipients, often resulting in severe illness and even death. The pandemic has further highlighted the significant risk that immunosuppressed patients, including allo‐HCT recipients, face when infected with SARS‐CoV‐2. As preventive transmission measures are relaxed and CARVs circulate again among the community, including in allo‐HSCT recipients, it is crucial to understand the current state of knowledge, gaps, and recent advances regarding CARV infection in allo‐HCT recipients. Urgent research is needed to identify seasonal respiratory viruses as potential drivers for future pandemics.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Review-3
content type line 23
ISSN:1398-2273
1399-3062
1399-3062
DOI:10.1111/tid.14117